Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus
Principal Investigator
Kevan Herold | Yale School of Medicine | New Haven, CT
Locations
Columbia University | New York,NY
University of California, San Francisco | San Francisco,CA
Study Code
ITN017AI
Study Status
Withdrawn
